NCT06510257View on ClinicalTrials.gov

Safety and Efficacy Reconyl for Cough With/Without Sore Throat

PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

July 23, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

October 3, 2024

Conditions

Cough

Interventions

DRUG

Reconyl

1 tablet of Reconyl, 3 times daily

DRUG

Placebo tablet of Reconyl

1 tablet of placebo Reconyl, 3 times daily

Trial Locations (2)

10430

Imeri Fkui, Jakarta Pusat

Unknown

Klinik Satelit Makara UI Depok, Depok

Sponsors

Lead Sponsor

Dexa Medica Group

All Listed Sponsors

collaborator

Fakultas Kedokteran Universitas Indonesia

OTHER

lead

Dexa Medica Group

INDUSTRY

NCT06510257 - Safety and Efficacy Reconyl for Cough With/Without Sore Throat | Biotech Hunter | Biotech Hunter